Skip to main content
X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
4.150
+0.390 (10.37%)
At close: Mar 9, 2026, 4:00 PM EDT
4.140
-0.010 (-0.24%)
After-hours: Mar 9, 2026, 5:04 PM EDT

X4 Pharmaceuticals Revenue

X4 Pharmaceuticals had revenue of $1.77M in the quarter ending September 30, 2025, with 215.18% growth. This brings the company's revenue in the last twelve months to $33.98M, up 2,925.73% year-over-year. In the year 2024, X4 Pharmaceuticals had annual revenue of $2.56M.

Revenue (ttm)
$33.98M
Revenue Growth
+2,925.73%
P/S Ratio
10.32
Revenue / Employee
$237,615
Employees
143
Market Cap
362.86M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20242.56M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 20203.00M--
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
C4 Therapeutics 35.95M
Bicycle Therapeutics 28.34M
Opus Genetics 14.63M
Absci 2.82M
Neurogene 925.00K
Revenue Rankings

XFOR News

More News